Site-specific cytosine methylation in S-COMT promoter in 31 brain regions with implications for studies involving schizophrenia

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 133 B, Issue 1, 2005, Pages 37-42

  Murphy, Brenda C ^a   O'Reilly, Richard L ^a   Singh, Shiva M ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

COMT; Discordant monozygotic twins; DNA methylation; Schizophrenia

Indexed keywords

CATECHOL METHYLTRANSFERASE; CYTOSINE; DNA; MESSENGER RNA;

ARTICLE; BLOOD; BRAIN REGION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA METHYLATION; DNA POLYMORPHISM; ENZYME ACTIVITY; EPIGENETICS; EXON; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; MONOZYGOTIC TWINS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RNA TRANSCRIPTION; SCHIZOPHRENIA;

ADULT; BASE SEQUENCE; BRAIN; CATECHOL O-METHYLTRANSFERASE; CPG ISLANDS; CYTOSINE; DNA; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; HUMANS; MOLECULAR SEQUENCE DATA; ONTARIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SCHIZOPHRENIA; TWINS, MONOZYGOTIC;

EID: 12944249385     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30134     Document Type: Article

References (36)

1. Bird AP. 1986. CpG-rich islands and the function of DNA methyaltion. Nature 321:209-213.
2. Brandeis M, Ariel M, Cedar H. 1993. Dynamics of DNA methylation during development. Biosessays 15:709-713.
3. Cardno AG, Marshall EJ, Coid B, Macdonald AM, Ribchester TR, Davies NJ, Venturi P, Jones LA, Lewis SW, Sham PC, Gottesman II, Farmer AE, McGuffin P, Reveley AM, Murray RM. 1999. Heritability estimates for psychotic disorders: The Maudsley twin psychosis series. Arch Gen Psych 56:162-168.
4. Chen X, Wang X, O'Neill AF, Walsh D, Kendler KS. 2004. Variants in the catechol-omethyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Mol Psychiatry 129B(1):23-26.
5. Feinberg AP, Tycko B. 2004. The history of cancer epigenetics. Nat Rev Can 4:143-153.
6. Fischer M. 1973. Genetic and environmental factors in schizophrenia: A study of schizophrenic twins and their families. Acta Psychiatr Scand 238(suppl):1-158.
7. Franzek E, Beckmann H. 1998. Different genetic background of schizophrenia spectrum psychosis: A twin study. Am J Psych 155:76-83.
8. Glatt SJ, Faraone SV, Tsuang MT. 2003. Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: Meta-analysis of case-control and family based studies. Am J Psychiatry 160:469-476.
9. Grossman MH, Littrell JB, Weinstein R, Szumlanski C, Weinshilboum RM. 1992. Identification of the possible molecular basis for inherited differences in human catechol O-methyltransferase. Trans Neurosci Soc 18:70 (Abstract).
10. Hallmayer J. 2000. The epidemiology of the genetic liability of schizophrenia. Aust NZ J Psych Nov 34(Suppl):S47-S55.
11. Jablensky A. 2000. Epidemiology of schizophrenia: The global burden of disease and disability. Eur Arch Psych Clin Neurosci 250:274-285.
12. Karlsson H, Bachmann S, Schroder J, McArthur J, Torrey EF, Yolken RH. 2001. Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. PNAS 98(8):4634-4639.
13. Kringlen E, Cramer G. 1989. Offspring of Monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry 46:873-877.
14. Lachman HM, Papolos DF, Saito T, Yu Y-M, Szumlanski CL, et al. 1996. Huamn catechol O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243-250.
15. Lee LT, Tan-Un KC, Pang RT, Lam DT, Chow BK. 2004. Regulation of the human secretin gene is controlled by the combined effects of CpG methyaltion, Sp1/Sp3 ratio and the E-Box element. Mol Endocrinol 18(7):1740-1755.
16. Lehmann U, Brakensiek K, Kreipe H. 2004. Role of epigenetic changes in hematological malignancies. Ann Hematol 83:137-152.
17. Mannisto PT, Kaakkola S. 1999. Catechol-O-methyltransferase (COMT): Biochemistry, molecular biology, pharmacology and clinical effiency of the new selective COMT inhibitors. Pharmaocol Rev 51:593-628.
18. McGuffin P, Tandon K, Corsico A. 2003. Linkage and association studies of schizophrenia. Curr Psychiatry Rep 5(2):121-127.
19. Mednick SA, Machon RA, Huttunen MO, Bonett D. 1988. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psych Feb 45(2):189-192.
20. Pedersen CB, Mortensen PB. 2001. Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk. Arch Gen Psych 58(11):1039-1046.
21. Petronis A. 2004. The origin of schizophrenia: Genetic thesis, epigenetic antithesis, and resolving synthesis. Biol Psychiatry 55:965-970.
22. Pompeia C, Hodge DR, Plass C, Wu YZ, Marquex VE, Kelley JA, Farra WL. 2004. Microarray analysis of epigenetic silencing of gene expression in the KAS-6/1 multiple myeloma cell line. Cancer Res 64(10):3465-3473.
23. Santos F, Dean W. 2004. Epigenetic reprogramming during early development in mammals. Reproduction 127:643-651.
24. Scanlon PD, Raymond FA, Weinshilboum RM. 1979. Catechol-O- methyltransferase: Thermolabile enzyme in erythrocytes of subjects homozygous for the allele for low activity. Science 203:63-65.
25. Sherman SL, DeFries JC, Gottesman II, Loehlin JC, Meyer JM, Pelias MZ, Rice J, Waldman I. 1997. Recent developments in human behavioural genetics: Past accomplishments and future directions. Am J Hum Genet 60:1265-1275.
26. Singh SM, Murphy B, O'Reilly R. 2002a. Epigenetic contributors to the discordance of monozygotic twins. Clin Genet 62:97-103.
27. Singh SM, Murphy B, O'Reilly R. 2002b. Monozygotic twins with chromosome 22q11 deletion and discordant phenotypes: Updates with an epigenetic hypothesis. J Med Genet 39:e71.
28. Singh SM, Murphy BC, O'Reilly R. 2003. Involvement of gene-diet/drug interaction in DNA methylation and its contribution to complex diseases: From cancer to schizophrenia. Clin Genet 64:451-460.
29. Singh SM, McDonald P, Murphy BC, O'Reilly R. 2004. Incidental neurodevelopmental episodes in the etiology of schizophrenia: An expanded model involving epigenetics and development. Clin Genet 65:435-440.
30. Smith KT, Coffee B, Reines D. 2004. Occupancy and synergistic activation of the FMR1 promoter by Nrf-1 and Sp1 in vivo. Hum Mol Genet 13(15):1611-1621.
31. Strous RD. Bark N, Woerner M, Lachman HM. 1997. Lack of association of a functional catechol O-methyltransferase gene polymorphism in schizophrenia. Biol Psychiatry 41:493-495.
32. Takahashi S, Cui YH, Kojima T, Han YH, Zhou RL, Kamioka M, Yu S, Matsuura M, Matsushima E, Wilcox M, Arinami T, Shen YC, Faraone SV, Tsuang MT. 2003. Family-based association study of markers on chromosome 22 in schizophrenia using African-American, European-American and Chinese families. Am J Med Genet Part B (Neuropsychiatric Genet) 120B:11-17.
33. Tenhunen J, Salminen M, Lundstrom K, Kiviluoto T, Savolainen R, Ulmanen I. 1994. Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem 223:1049-1059.
34. Tienari PJ, Wynne LC. 1994. Adoption studies of schizophrenia. Ann Med Aug 26(4):233-237.
35. Torrey EF, Miller J, Rawlings R, Yolken RH. 1997. Seasonality of births in schizophrenia and bipolar disorder: A review of the literature. Schizphre Res 28(1):1-38.
36. Wondoi I, Stine OC, Mitchell BD, Buchanan RW, Thaker GK 2003. Association between Vall08/158 Met polymorphism of the COMT gene and schizophrenia. Am J Med Genet 120B(1):47-50.